Severe gout is a disease with high prevalence and often confronts physicians, reumatologists but also emergency physicians. DREAM started monitoring gout care and outcomes in August 2017. We hope to establish what role uricosuric agents play in the treatment of severe gout and which outcomes are the most important to patients. This will clarify what can be improved in the treatment of severe gout. 

DREAM-gout was initiated by dr. Tim Jansen, Viecuri.